Lorcaserin Phase 3 Clinical Trial In Patients With Type 2 Diabetes Shows Statistically Significant Weight Loss

Podiatry Arena Lorcaserin Phase 3 Clinical Trial In Patients With Type 2 Diabetes Shows Statistically Significant Weight Loss

Welcome to the Podiatry Arena forums, for communication between foot health professionals about podiatry and related topics.

You are currently viewing our podiatry forum as a guest which gives you limited access to view all podiatry discussions and access our other features. By joining our free global community of Podiatrists and other interested foot health care professionals you will have access to post podiatry topics (answer and ask questions), communicate privately with other members (PM), upload content, view attachments, receive a weekly email update of new discussions, earn CPD points and access many other special features. Registered users do not get displayed the advertisments in posted messages. Registration is fast, simple and absolutely free so please, join our global Podiatry community today!

If you have any problems with the registration process or your account login, please contact contact us.

Lorcaserin Phase 3 Clinical Trial In Patients With Type 2 Diabetes Shows Statistically Significant Weight Loss

Submit Thread >

< Submit Thread

Thread Tools

Display Modes

10th November 2010, 10:30 AM

RSSFeedBot RSSFeedBot is offline

I, Robot

About:

Join Date: Jul 2008

Posts: 10,129

Join Date: Jul 2008

Marketplace reputation 0% (0)

CPD Points: 1

Thanks: 0

Thanked 22 Times in 22 Posts

Lorcaserin Phase 3 Clinical Trial In Patients With Type 2 Diabetes Shows Statistically Significant Weight Loss

Podiatry Arena members do not see these ads

Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) and Eisai Inc. reported that top-line results from the one-year lorcaserin BLOOM-DM trial demonstrate statistically significant weight loss in obese and overweight patients with type 2 diabetes. In this trial, lorcaserin met all three co-primary efficacy endpoints...

More...

Sponsored Links

« Previous Thread | Next Thread »

Thread Tools
Show Printable Version Email this Page
Display Modes
Switch to Linear Mode Hybrid Mode Switch to Threaded Mode

Posting Rules
You may not post new threads You may not post replies You may not post attachments You may not edit your posts	vB code is On Smilies are On [IMG] code is On HTML code is On

Forum Jump

Translate This Page

Similar Threads

Thread	Thread Starter	Forum	Replies	Last Post
Clinical Trial Using ALRT Health-e-Connect (HeC) System On Diabetes Patients Shows 1.2% Drop In A1C	RSSFeedBot	Latest Diabetes Medicine Research & News	0	3rd August 2010 06:20 AM
Exsulin Corporation Announces Next Phase II Trial Of Novel Islet Regeneration Treatment In Type 1 Diabetes	RSSFeedBot	Latest Diabetes Medicine Research & News	0	11th September 2009 05:41 AM
CytRx Announces Significant Efficacy Results In A Pre-Clinical Trial With Iroxanadine For Diabetic Peripheral Neuropathy	RSSFeedBot	Latest Diabetes Medicine Research & News	0	20th March 2009 06:10 AM
Newly Phase 3 Data Confirm Liraglutide Lowers Blood Sugar And Weight In Type 2 Diabetes Patients	RSSFeedBot	Latest Diabetes Medicine Research & News	0	8th February 2009 06:21 AM

New To Site?	Need Help?
Register to Participate View Forum Leaders Contact Us	Frequently Asked Questions Did you forget your password? Mark Forums Read

Finding your way around:

Browse the forums.

Search the site.

Browse the tags.

Search the tags.

All times are GMT -7. The time now is 07:25 AM.

User Name		Remember Me?
Password